Osteoporosis Therapeutics Market: - Global Growth, Trends and Forecast (2022-2029) By Types (Bisphosphonates, Hormones, Strontium Ranelate, Raloxifene, Denosumab) By Application (Hospital Pharmacies, Online Pharmacies) and By Regions

Who are the Major Players in Osteoporosis Therapeutics Market?

Competitive landscape of the global Osteoporosis Therapeutics market comprises key companies on a regional and global level. Key players are engaged in developing innovative and advanced products and solutions to cater to growing global demand and expand their product portfolio to gain a robust footing in the market. Collaborations, mergers and acquisitions, and partnerships are a crucial part in the market.

An exhaustive analysis of the competitive hierarchy of the Osteoporosis Therapeutics market is presented in the report and encompasses companies like Warner Chilcott, Merck & Co., Roche, Novartis, Ono, Astellas Pharma, Procter & Gamble, Sumitomo Pharmaceuticals, Servier, Eli Lilly, Pfizer, Amgen, Chugai, and others.

Industry News:

In October 2021, Entera Bio, a leading biotechnology company, posted crucial data for its oral osteoporosis drug formulation trial that is in its mid-stage. The company moved ahead to phase 3 registrations of this study.

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

April 9, 2019 Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. Food and Drug Administration (FDA) has approved EVENITY™ (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at high risk for fracture. EVENITY is the first and only bone builder with a unique dual effect that both increases bone formation and to a lesser extent reduces bone resorption (or bone loss) to rapidly reduce the risk of fracture.

Osteoporosis Therapeutics Market: Segmentation

On the basis of product type, the Osteoporosis Therapeutics market in segmented into:

• Bisphosphonates
• Hormones
• Strontium Ranelate
• Raloxifene
• Denosumab
• Others

On the basis of application, the Osteoporosis Therapeutics market in segmented into:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Osteoporosis Therapeutics Market Regional Analysis

The osteoporosis therapeutics market in North America is projected to have a promising future and will hold a commanding market share in the global landscape.

Throughout the forecast period, the global osteoporosis therapeutics market is anticipated to have considerable growth in Europe. The market potential for osteoporosis therapies in this region is anticipated to be significantly impacted by rising spending on research and development activities.

Osteoporosis therapeutics market players should find profitable prospects in South and East Asia. The aging population and rising healthcare costs in the aforementioned regions are predicted to have a significant impact on the growth of the osteoporosis therapeutics market.

The aging population in China has grown noticeably, and this will heavily influence the shipments of osteoporosis medications throughout the course of the projection year. Other aspects that are anticipated to influence the growth of the osteoporosis therapeutics market include growing healthcare costs and increased awareness of osteoporosis.

China, India, and Malaysia are expected to be lucrative markets for manufacturers of osteoporosis medications.

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Middle East & Africa
  • Latin America

The Osteoporosis Therapeutics Market identifies the market channels and drivers that will drive future worldwide growth prospects. The report also examines market size and share, trends by region, end-use category, and market segment. It puts a lot of emphasis on outlining a thorough regional study. In order to understand the primary influencing factors and entry barriers of the industry, the Global Osteoporosis Therapeutics Market research also performed a PESTEL analysis of the sector.

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.

1. INTRODUCTION
   1. MARKET DEFINITION
   2. MARKET DYNAMICS
   3. MARKET SEGMENTATION
   4. REPORT TIMELINES
   5. KEY STAKEHOLDERS
2. RESEARCH METHODOLOGY
   1. DATA MINING
      1. SECONDARY RESEARCH
      2. PRIMARY RESEARCH
      3. SUBJECT MATTER EXPERT ADVICE
   2. QUALITY CHECK
   3. FINAL REVIEW
      1. DATA TRIANGULATION
      2. BOTTOM-UP APPROACH
      3. TOP-DOWN APPROACH
      4. RESEARCH FLOW
3. EXECUTIVE SUMMARY
   1. INTRODUCTION
   2. GLOBAL OSTEOPOROSIS THERAPEUTICS MARKET BY TYPE
   3. GLOBAL OSTEOPOROSIS THERAPEUTICS MARKET ON APPLICATION
4. MARKET DYNAMICS
   1. DRIVERS
      1. INCREASING DEMAND FOR EPIGENOMIC RESTRAINTS
      2. STRINGENT ENVIRONMENTAL REGULATIONS
      3. HIGH COST OF MATERIALS
   2. OPPORTUNITIES
      1. BRONCHITIS TREATMENT GROWTH
      2. END USER OF OPHTHALMOLOGY DRUGS AND DEVICES MARKET
      3. IMPACT OF COVID 19
5. GLOBAL OSTEOPOROSIS THERAPEUTICS MARKET, BY TYPE
   1. INTRODUCTION
   2. BISPHOSPHONATES
   3. HORMONES
   4. STRONTIUM RANELATE
   5. RALOXIFENE
   6. DENOSUMAB
   7. OTHERS
6. GLOBALOSTEOPOROSIS THERAPEUTICS MARKET, BY APPLICATION
   1. INTRODUCTION
   2. HOSPITAL PHARMACIES
   3. ONLINE PHARMACIES
   4. RETAIL PHARMACIES
7. GLOBALEPIGENOMIC MARKET, BY REGION
   1. NORTH AMERICA
      1. US
      2. CANADA
      3. MEXICO
   2. EUROPE
      1. GERMANY
      2. FRANCE
      3. UK
      4. ITALY
      5. RUSSIA
      6. REST OF EUROPE
   3. APAC
      1. CHINA
      2. SOUTH KOREA
      3. JAPAN
      4. INDIA
      5. AUSTRALIA
      6. ASEAN
      7. REST OF APAC
   4. MIDDLE EAST AND AFRICA
      1. SAUDI ARABIA
      2. UAE
      3. SOUTH AFRICA
      4. TURKEY
      5. REST OF MEA
   5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF MEA
      3. ARGENTINA
      4. REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
   1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
   2. AND AGREEMENTS
      1. KEY DEVELOPMENT
   3. MARKET SHARE /RANKING ANALYSIS
   4. STRATEGIES ADOPTED BY LEADING PLAYERS
9. COMPANY PROFILES
   1. BUSINESS OVERVIEW
   2. COMPANY SNAPSHOT
   3. PRODUCT BENCHMARKING
   4. STRATEGIC INITIATIVES
      1. WARNER CHILCOTT
      2. MERCK & CO.
      3. ROCHE
      4. NOVARTIS
      5. ONO
      6. ASTELLAS PHARMA
      7. PROCTER & GAMBLE
      8. SUMITOMO PHARMACEUTICALS
      9. SERVIER
      10. ELI LILLY
      11. PFIZER
      12. AMGEN
      13. CHUGAI

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.